热门资讯> 正文
Quoin Pharmaceuticals任命Sally Lawlor为CFO
2025-08-18 20:36
- Quoin Pharmaceuticals (NASDAQ:QNRX) on Monday announced the appointment of Sally Lawlor as its new Chief Financial Officer as the company advances its lead product candidate, QRX003, through pivotal clinical studies and prepares for potential commercialization.
- In her most recent role at Sebela Pharmaceuticals, Lawlor managed financial reporting under U.S. GAAP and IFRS, oversaw global tax planning and compliance, as well as budgeting, forecasting, and external audits.
- Source: Press Release
More on Quoin Pharmaceuticals
- Seeking Alpha’s Quant Rating on Quoin Pharmaceuticals
- Historical earnings data for Quoin Pharmaceuticals
- Financial information for Quoin Pharmaceuticals
推荐文章
新股申购 | 长风药业今起招股！一手入场费7449.38港元
华盛早报 | 最高100%！特朗普宣布关税“连环炮”：涉药品、卡车和家具；小米美股ADR涨超4%
英特尔(INTC.US)成市场新宠！投资者抢购看涨期权押注涨势延续
美股机会日报 | 黄仁勋再度减持英伟达！涉资超4000万美元；美银发声：标普500指数没有泡沫
瑞银：全球第二大铜矿印尼Grasberg矿难停产 料明年全球铜供需缺口扩大 行业看好紫金矿业等
美股躲过“九月魔咒”？高盛警告：10月飓风又将来袭
昔日大客户苹果(AAPL.US)或成“救星”？ 英特尔(INTC.US)广发“英雄帖”求投资助力复兴
9月25日外盘头条：美对欧汽车关税调降至15% 英特尔寻求苹果投资合作 甲骨文进行今年第二大发债交易
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
